Unlocking the Value of Combination Therapies
![unlocking the value of combination therapies](https://www.ohe.org/wp-content/uploads/2024/07/unlocking-the-value-of-combination-therapies-scaled.jpeg)
Our work in health economics, health policy and health statistics informs decision-making about health care and pharmaceutical issues at a global level.
of rare diseases have a single-gene cause
is the likelihood of developing dementia, becoming an informal carer, or both in a lifetime
of the NHS’s total carbon footprint accounts for the manufacture, supply, and use of pharmaceuticals
clinical trials supported the first digital therapeutic recommended by NICE